Abstract Nanoparticle drug delivery systems have been used in the clinic since the early 1990's. Since that time, the field of nanomedicine has evolved alongside growing technological needs to improve the delivery of various therapeutics. Over these past decades, newer generations of nanoparticles have emerged that are capable of performing additional delivery functions that can…
Bioengineering & Translational Medicine Template
Write in a clean editor, then format for Bioengineering & Translational Medicine in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Bioengineering & Translational Medicine format
Bioengineering & Translational Medicine is a peer-reviewed journal published by Wiley, covering 3D Printing in Biomedical Research, RNA Interference and Gene Delivery, Nanoplatforms for cancer theranostics.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Bioengineering & Translational Medicine 12 (3): 45–58.
Formats any DOI in Bioengineering & Translational Medicine style. No sign-up. |
| Publishes research in | 3D Printing in Biomedical Research RNA Interference and Gene Delivery Nanoplatforms for cancer theranostics Tissue Engineering and Regenerative Medicine Nanoparticle-Based Drug Delivery |
| ISSN | 2380-6761 |
| Citation impact (2-yr) | 4.53 |
| h-index | 72 |
| i10-index | 493 |
| Total citations | 25,402 |
| Article processing charge | $2,100 |
| Open access | Yes |
| Top institutions publishing here | Harvard University |
| Journal website | aiche.onlinelibrary.wiley.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Bioengineering & Translational Medicine per year
Citation impact of Bioengineering & Translational Medicine by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Bioengineering & Translational Medicine
Nanoparticle/microparticle-based drug delivery systems for systemic (i.e., intravenous) applications have significant advantages over their nonformulated and free drug counterparts. For example, nanoparticle systems are capable of delivering therapeutics and treating areas of the body that other delivery systems cannot reach. As such, nanoparticle drug delivery and imaging systems are one of the most investigated systems…
Injectable hydrogels are one of the most widely investigated and versatile technologies for drug delivery and tissue engineering applications. Hydrogels' versatility arises from their tunable structure, which has been enabled by considerable advances in fields such as materials engineering, polymer science, and chemistry. Advances in these fields continue to lead to invention of new polymers,…
Gelatin is a promising material as scaffold with therapeutic and regenerative characteristics due to its chemical similarities to the extracellular matrix (ECM) in the native tissues, biocompatibility, biodegradability, low antigenicity, cost-effectiveness, abundance, and accessible functional groups that allow facile chemical modifications with other biomaterials or biomolecules. Despite the advantages of gelatin, poor mechanical properties, sensitivity…
Ionizable lipid nanoparticles (LNPs) are the most clinically advanced nano-delivery system for therapeutic nucleic acids. The great effort put in the development of ionizable lipids with increased in vivo potency brought LNPs from the laboratory benches to the FDA approval of patisiran in 2018 and the ongoing clinical trials for mRNA-based vaccines against SARS-CoV-2. Despite…